Phil Nadeau

Stock Analyst at TD Cowen

(1.97)
# 760
Out of 5,299 analysts
32
Total ratings
47.37%
Success rate
38.61%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
KURA Kura Oncology
Reiterates: Buy
n/a
n/a n/a 1 Nov 21, 2024
SYRS Syros Pharmaceutical...
Downgrades: Hold
n/a
n/a n/a 1 Nov 13, 2024
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
55 65
54.9 18.4% 2 Nov 6, 2024
BIIB Biogen
Maintains: Buy
300 275
119.14 130.82% 6 Oct 31, 2024
BMRN Biomarin Pharmaceuti...
Maintains: Buy
125 120
59.24 102.57% 1 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
450 500
474.3 5.42% 7 Jul 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Feb 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Apr 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
n/a n/a 1 May 26, 2017